-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RTwsMNmQnfQNspg5tY4K9hzgPyc/YxIXvDyL5ybOPDfw8CdSOiIMqgASv/09WAJI ndUQvicwcR6ZC5l7lzTxYg== 0001209191-05-043958.txt : 20050822 0001209191-05-043958.hdr.sgml : 20050822 20050822192124 ACCESSION NUMBER: 0001209191-05-043958 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050818 FILED AS OF DATE: 20050822 DATE AS OF CHANGE: 20050822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EVNIN LUKE CENTRAL INDEX KEY: 0001134657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 051042254 BUSINESS ADDRESS: STREET 1: ONE CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: C/O MPM ASSET MANAGEMENT STREET 2: 111 HUNTINGTON AVE., 31ST FLOOR CITY: BOSTON STATE: MA ZIP: 02199 4 1 bsf12038_bsf1le.xml MAIN DOCUMENT DESCRIPTION X0202 4 2005-08-18 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001134657 EVNIN LUKE C/O MPM ASSET MANAGEMENT 111 HUNTINGTON AVE., 31ST FLOOR BOSTON MA 02199 1 0 0 0 Common Stock 2005-08-18 4 S 0 225000 2.5296 D 6947050 I See footnote Common Stock 2005-08-19 4 S 0 60000 2.3528 D 6887050 I See footnote Common Stock 2005-08-19 4 S 0 100000 2.42 D 6787050 I See footnote Common Stock 2005-08-22 4 S 0 50000 2.2936 D 6737050 I See footnote Common Stock 2005-08-22 4 S 0 150000 2.28 D 6587050 I See footnote The shares were sold as follows: 197,067 by BB BioVentures L.P. ("BB BV"), 25,345 by MPM BioVentures Parallel Fund, L.P. ("BV PF") and 2,588 by MPM Asset Management Investors 1998 LLC ("AM 1998"). MPM BioVentures I, L.P. ("BV I") and MPM BioVentures I LLC ("BV I LLC") are the direct and indirect general partners of BV PF. BAB BioVentures L.P. ("BAB BV") and BAB BioVentures, N.V. ("BAB NV") are the direct and indirect general partners of BB BV. The Reporting Person is a manager of BAB NV, AM 1998 and BV I LLC. The shares are held as follows: 6,084,555 by BB BV, 782,607 by BV PF and 79,888 by AM 1998. The Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein. The shares were sold as follows: 52,551 by BB BV, 6,759 by BV PF and 690 by AM 1998. The shares are held as follows: 6,032,004 by BB BV, 775,848 by BV PF and 79,198 by AM 1998. The Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein. The shares were sold as follows: 87,585 by BB BV, 11,265 by BV PF and 1,150 by AM 1998. The shares are held as follows: 5,944,419 by BB BV, 764,583 by BV PF and 78,048 by AM 1998. The Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein. The shares were sold as follows: 43,793 by BB BV, 5,632 by BV PF and 575 by AM 1998. The shares are held as follows: 5,900,626 by BB BV, 758,951 by BV PF and 77,473 by AM 1998. The Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein. The shares were sold as follows: 131,378 by BB BV, 16,897 by BV PF and 1,725 by AM 1998 The shares are held as follows: 5,769,248 by BB BV, 742,054 by BV PF and 75,748 by AM 1998. The Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein. /s/ Luke Evnin 2005-08-22 -----END PRIVACY-ENHANCED MESSAGE-----